-23.8%
TEAM vs GSK
+58.9%
-82.7%
-82.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.0% | -2.3% | -3.7% | -6.2% |
| 7D | -5.1% | -3.0% | -2.1% | -5.4% |
| 30D | -32.2% | +0.4% | -32.5% | -32.1% |
| 3M | -11.0% | -1.2% | -9.8% | -11.0% |
| 6M | +61.2% | +0.9% | +60.3% | +62.0% |
| YTD | -13.1% | +4.0% | -17.0% | -13.7% |
| 1Y | -3.5% | +7.3% | -10.7% | -4.1% |
| 3Y | -23.8% | +57.1% | -80.9% | -22.5% |
| All | -23.8% | +58.9% | -82.7% | -22.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling